Elderly AML & Burkitt Lymphoma Updates
Nov 09, 2023•25 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Aggressive hematologic malignancy publications can be challenging to interpret and translate to clinical practice.
We look at two recent studies to illustrate this point.
Elderly AML: 10-day decitabine vs. 7 + 3 (https://doi.org/10.1016/S2352-3026(23)00273-9)
Burkitt Lymphoma: R-CODXO-M/R-IVAC vs. DA-R-EPOCH (https://doi.org/10.1016/S2352-3026(23)00279-X)
For the best experience, listen in Metacast app for iOS or Android